Medical applications of haplotype-based SNP maps: learning to walk before we run (original) (raw)

Nature Genetics volume 32, page 353 (2002)Cite this article

Ever since Risch and Merikangas1 introduced the concept of whole-genome association using single-nucleotide polymorphisms (SNPs) in 1996, the question of how many SNPs would be required for whole-genome association studies has been extensively debated2,3. The initial prediction of one million SNPs has recently been reduced to approximately 300,000 (ref. 4). Furthermore, it is clear that chromosomally mapped and ordered SNP variants can be grouped into bins/blocks as distinct 'haplotypes'5,6. Recently, the National Human Genome Research Institute proposed the development of a map of the common haplotype patterns in at least three ethnic populations.

The scientific community is currently divided regarding the perceived need for genome-wide maps of common haplotype blocks. Most support the proposal of constructing haplotype maps to maximize information content and to minimize the number of SNPs required for whole- genome genotyping. The scope of its utility is, however, bounded. Its applicability may not extend beyond the ethnic groups chosen, and is limited by the representativeness of the few samples studied. Furthermore, rare and sometimes detrimental variants are the ones most likely to be missed entirely from the derived SNP set. Pharmacogenetics focuses on the prediction of safety and efficacy following pharmaceutical treatment and clearly stands to benefit from the increased efficiency of a complete haplotype map. A practical question is whether common haplotype maps for several ethnic populations are essential, or even necessary, for immediate pharmacogenetic applications to advance.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Risch, N. & Merikangas, K. Science 273, 1516–1517 (1996).
    Article CAS Google Scholar
  2. Kruglyak, L. Nat. Genet. 22, 139–144 (1999).
    Article CAS Google Scholar
  3. Collins, A., Lonjou, C. & Morton, N.E. Proc. Natl Acad. Sci. USA 96, 15173–15177 (1999).
    Article CAS Google Scholar
  4. Patil, N. et al. Science 294, 1719–1723 (2001).
    Article CAS Google Scholar
  5. Johnson, G. et al. Nat. Genet. 29, 233–237 (2001).
    Article CAS Google Scholar
  6. Daly, M. et al. Nat. Genet 29, 229–232 (2001).
    Article CAS Google Scholar
  7. Hetherington, S. et al. Lancet 359, 1121–1122 (2002).
    Article CAS Google Scholar
  8. Mallal, S. et al. Lancet 359, 727–732 (2002).
    Article CAS Google Scholar
  9. Roses, A.D. Nature Rev. Drug Disc. 1, 541–549 (2002).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Genetics Research, GlaxoSmithKline, Research Triangle Park, 27709, North Carolina, USA
    Eric Lai, Clive Bowman, Aruna Bansal, Arlene Hughes, Michael Mosteller & Allen D. Roses

Authors

  1. Eric Lai
    You can also search for this author inPubMed Google Scholar
  2. Clive Bowman
    You can also search for this author inPubMed Google Scholar
  3. Aruna Bansal
    You can also search for this author inPubMed Google Scholar
  4. Arlene Hughes
    You can also search for this author inPubMed Google Scholar
  5. Michael Mosteller
    You can also search for this author inPubMed Google Scholar
  6. Allen D. Roses
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toAllen D. Roses.

Rights and permissions

About this article

Cite this article

Lai, E., Bowman, C., Bansal, A. et al. Medical applications of haplotype-based SNP maps: learning to walk before we run.Nat Genet 32, 353 (2002). https://doi.org/10.1038/ng1102-353

Download citation

This article is cited by